OncologyCAR-T Cell Therapy

CAR-T Cell Therapy

Dr. Akash Khandelwal
Dr. Akash Khandelwal

Consultant - Haemato-Oncology & BMT

Fortis Hospital, Shalimar Bagh, New Delhi, India

Masterclass held Published

Dr. Akash Khandelwal, Consultant Hemato-Oncology & BMT, Fortis Hospital, Shalimar Bagh, New Delhi, India, explained how CAR-T cell therapy re-engineers a patient's own T-cells to target cancer, from collection and manufacturing to infusion. He covered its approved use in relapsed or refractory B-cell lymphoma and leukaemia, the complications that need close monitoring, patient outcomes, and the cost and availability of CAR-T in India.

Access the Article Series

  1. 1.CAR-T Cell Therapy: A Complete Guide
  2. 2.CAR-T Cell Therapy Timeline: From Collection to Recovery
  3. 3.Who Is Eligible for CAR-T Cell Therapy? Outcomes and Access
  4. 4.Live Discussion: 7 questions from doctors, answered by Dr. Akash Khandelwal

For Doctors

Join the Jivo Doctor NetworkRegister for the next masterclass

Book a Consultation with Dr. Akash Khandelwal

Book on WhatsApp

Or message us on WhatsApp: +91 98182 98669

← Back to All Masterclasses